BioInvent International AB: Interim Report January-June 2024

LUND, SWEDEN / ACCESSWIRE / August 29, 2024 / BioInvent International (STO:BINV)"The presentation of promising results from our two lead drug candidates at the ASCO Annual Meeting showcased their potential as first-in-class immunomodulatory agents …
Jetzt den vollständigen Artikel lesen